Projects and Grants per year
Grants and Contracts Details
Description
The aryl hydrocarbon receptor (AHR) may play in important role in the etiology of tobacco smoke induced
lung cancer and may also be an important target for effective chemopreventive approaches. Our initial
data performed in human lung epithEllial cells indicates that constituents present in cigarette smoke
condensate can act as AHR agonists and that several dietary flavonoids, in particular, apigenin, emodin
and kaempferol appear to act as effective AHR antagonists.
The hypothesis to be tested in this proposal is that the AHR is an important pharmacological target of
dietary flavonoids that will be effective for chemoprevention of tobacco smoke induced lung cancer.
Specific Aims: (1) Determine the e):tent to which cigarette smoke condensate activates and flavonoids
inhibit the AHR and cell transformation. (2) Determine whether apigenin inhibits cigarette smoke
condensate-induced malignant transformation of human lung epithelial cells in vivo.
Status | Finished |
---|---|
Effective start/end date | 9/18/06 → 8/31/09 |
Funding
- National Cancer Institute
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 1 Finished
-
Chemopreventive properties of aryl hydorcarbon receptor antagonists
Swanson, H. & Gairola, C.
9/18/06 → 8/31/09
Project: Research project